An automated platform for the large-scale production of miniaturized neuromuscul...
An automated platform for the large-scale production of miniaturized neuromuscular organoids
Organoids have been developed as advanced 3D cell culture systems that resemble aspects of the in vivo tissues and provide an alternative to study the mechanisms of human disease and identify novel treatments. The last years have...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
eNeuroMus
Deciphering the impact of bioelectrical communication on hum...
174K€
Cerrado
EQC2019-006657-P
Plataforma automatizada para imagen de célula sencilla viva
185K€
Cerrado
GPSorganoids
Generation of Position Specific organoids to study human neu...
3M€
Cerrado
PLEC2022-009341
ZeNeuroid: Red de organoides neuronales humanos para el desc...
364K€
Cerrado
BROOC
Brain organoid-on-chip: a microfluidic platform to study neo...
190K€
Cerrado
ORGESTRA
Organoid technologies for disease modeling, drug discovery a...
3M€
Cerrado
Información proyecto MiniOrgans
Duración del proyecto: 18 meses
Fecha Inicio: 2023-06-19
Fecha Fin: 2024-12-31
Descripción del proyecto
Organoids have been developed as advanced 3D cell culture systems that resemble aspects of the in vivo tissues and provide an alternative to study the mechanisms of human disease and identify novel treatments. The last years have witnessed tremendous developments in the field of stem cell and organoid research, but the full potential of these systems remains to be exploited. Two major challenges facing the organoid field are reproducibility and scalability. The manual production of organoids is a labor-intensive and expensive process. The development of cost-effective, fast, and reliable methods is a prerequisite for transferring organoid technologies to the industry for high-throughput approaches. We have recently established a novel complex human neuromuscular organoid (NMO) model from human pluripotent stem cell-derived neuromesodermal progenitors. NMOs self-organize into spinal cord neurons and skeletal muscle compartments that contract by forming functional neuromuscular junctions. The ERC consolidator grant GPSorganoids focuses on the generation of position-specific (GPS) NMOs representing distinct spinal cord segments and the use of such NMOs models to study the selective vulnerability of specific spinal cord neurons to neuromuscular diseases like amyotrophic lateral sclerosis and spinal muscular atrophy. The PoC grant goes beyond the scope of our ERC consolidator grant and focuses on the commercialization of the NMO model through the establishment of an automated, reliable, and high throughput production line that could apply to industry settings. Our ultimate goal is to establish NMOs as a leading model in the market for high throughput drug screening approaches and accelerate the development of novel therapies for neuromuscular disorders.